A 2025 Third-Party Analysis of Safety Outcomes and Cost Savings for Complex Pediatric Conditions.
Proven Savings. Unmatched Safety.
A comprehensive 2025 study conducted by Charm Economics has quantified the impact of Cubby Beds on the Medicaid population. The data reveals significant cost reductions driven by diverted emergency department (ED) visits and inpatient admissions, alongside measurable improvements in safety and medication reduction.
Key Highlights:
- Rapid ROI: Investment payback period estimated at less than 1 year for high-need populations.
- Injury Reduction: Safety behavior scores improved by 31% to 41% across surveyed conditions.
- Substantial Savings: Annual Medicaid savings range from $7,860 to over $24,000 per child, depending on the diagnosis.
2. Financial Impact & ROI: Reducing Healthcare Costs Through Prevention
By providing a safe sleep environment, Cubby Beds significantly reduce the frequency of costly medical interventions related to sleep behaviors, falls, and elopement.
Annual Medicaid Savings Per Child (Year 1)
-
Down Syndrome: $24,630 projected annual savings.
- Driven largely by a $21,761 reduction in inpatient admission costs.
-
Autism (Levels 2 & 3): $7,860 projected annual savings.
- Driven by reductions in ED visits ($833) and hospital admissions ($6,413)
-
Seizure Disorders: $7,873 projected annual savings.
- Driven by a $2,652 reduction in ED visits and $5,221 in hospital admissions.
Lifetime Value (10-Year Horizon)
The cumulative savings amplify significantly over the lifespan of the device:
- Down Syndrome: $147,660 total 10-year savings.
- Seizure Disorder: $47,199 total 10-year savings.
- Autism (Levels 2 & 3): $47,123 total 10-year savings.
3. Clinical & Safety Outcomes: Data-Backed Safety Improvements
Analyzing caregiver survey data regarding injury frequency and severity before and after Cubby Bed implementation shows a drastic reduction in harm.
Reduction in Injury Risk
The study calculated an "Injury Score Percent Decrease" based on caregiver reporting of self-injury, falls, and entrapment:
- Down Syndrome: 41.4% decrease in injury score.
- Seizure Disorder: 31.3% decrease in injury score.
- Autism: 31.2% decrease in injury score.
Reduction in Pharmaceutical Reliance
Caregivers reported a decrease in the need for pharmaceutical interventions (medications for sleep, anxiety, or behavior) after introducing the Cubby Bed.
- 50% of Down Syndrome caregivers reported "Definitely" or "Maybe" decreasing Rx use.
- 43% of Autism caregivers reported "Definitely" or "Maybe" decreasing Rx use.
4. Study Methodology: Rigorous, Third-Party Validation
This data was synthesized by Charm Economics (2025) utilizing a two-pronged approach:
- ROI Modeling: Utilizing national Medicaid claims data and prevalence statistics for Autism (Levels 2&3), Childhood Epilepsy, and Down Syndrome to calculate Diverted ED Visits and Inpatient Admissions.
- Caregiver Survey: A detailed survey of existing Cubby Bed users measuring changes in sleep duration, wake-ups, safety incidents (injuries/medical procedures), and financial implications.
Target Population Analyzed:
The study focused on high-acuity pediatric populations, including:
- Autism (Levels 2 & 3)
- Seizure Disorders / Epilepsy
- Down Syndrome
- Cerebral Palsy
- Intellectual Disabilities